Velcade®^▼

A patient information leaflet is included in every pack of medicine. You should read this carefully before taking your medicine.

The patient information leaflet for Velcade® can be found here.

If you have any questions about a condition or medicine, always consult a healthcare professional.

Velcade® is a medicine used to kill cancer cells in patients with multiple myeloma (cancer of the bone marrow). The active substance is bortezomib.

Velcade® belongs to a group of medicines called cytotoxic medicinal products. These are used to kill cancer cells.

Velcade® is used for the treatment of adults with cancer of the bone marrow (multiple myeloma). It is prescribed with other drugs called melphalan and prednisone, for patients who have not been previously treated for multiple myeloma and who are not eligible for high-dose chemotherapy with bone marrow transplant.

Velcade® is also prescribed for patients who have received at least one prior treatment and whose disease is worsening on their last treatment. Velcade® should be used for patients who have already undergone or who cannot undergo bone marrow transplantation.

The most common side effects are: Sensitivity, numbness, tingling or burning sensation of the skin, or pain in the hands or feet, Reduction in the number of red or white blood cells, anaemia caused by destruction of red blood cells, Fever, shivering fits,Shortness of breath without exercise , Feeling sick in the stomach or vomiting, loss of appetite, Constipation with or without bloating, Diarrhoea, if this happens, it is important to drink more water than usual. Your doctor may give you another medicine to control diarrhoea while you are receiving Velcade®, Tiredness, Loss of appetite, Headache.

For further information on Velcade®, including possible side effects, please refer to the patient information leaflet or speak to your doctor.

Patient Information Leaflets:

Item code: VEL/09-0061
Date of Preparation: October 2009